BioLife Solutions Inc. (BLFS) Dividend History

BioLife Solutions Inc. (BLFS) is a provider of biopreservation tools and systems for the long-term storage of cells, tissues, and organs. The company develops and markets advanced cryopreservation media, controlled-rate thawing systems, and other bioprocessing products primarily serving the biopharmaceutical, cell and gene therapy, and regenerative medicine industries. BioLife Solutions aims to improve the safety and efficacy of cell-based therapies through its innovative preservation technology.

3303 Monte Villa Parkway, Bothell, WA, 98021
Phone: (425) 401-1400
Website: https://www.biolifesolutions.com

Dividend History

BioLife Solutions Inc. currently does not pay dividends

Company News

BioLife Solutions to Participate in Upcoming Investor Conferences in May and June 2025

BioLife Solutions, a leading developer and supplier of bioproduction products and services for the cell and gene therapy market, announced its participation in several upcoming investor conferences in May and June 2025.

Benzinga
BioLife Solutions Updates Earnings Call Information

BioLife Solutions, a leading developer and supplier of cell processing tools and services for the cell and gene therapy market, is announcing corrected call-in numbers for their Earnings Call this afternoon.

Benzinga
BioLife Solutions Reports First Quarter 2025 Financial Results

BioLife Solutions reported strong Q1 2025 results, with 33% year-over-year growth in cell processing revenue and improved profitability. The company is well-positioned to continue advancing innovative solutions for the growing cell and gene therapy market.

Benzinga
Global Cryopreservation Freezers Market to Reach USD 1,233.7 Million by 2035, Driven by Advancements in Regenerative Medicine and Stem Cell Banking | Future Market Insights, Inc.

The cryopreservation freezers market is expected to grow significantly, driven by advancements in regenerative medicine, stem cell banking, and biobanking. Key factors driving growth include rising demand for biobanking, technological advancements, and increasing adoption in the pharmaceutical and biotechnology sectors.

GlobeNewswire Inc.

Featured Companies: GTLS
BioLife Solutions to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on March 3, 2025

BioLife Solutions, a leading developer and supplier of bioproduction products and services for the cell and gene therapy market, will report its Q4 and full-year 2024 financial results on March 3, 2025.

Benzinga

Dividend data last updated 06/07/2025 05:44:10 UTC